7 completed, 3 terminated, 3 unknown, 1 withdrawn. 14 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 7, Terminated 3, Unknown 3, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Ketoconazole: new trials by email Literature Review of Ketoconazole trials Research Report on Ketoconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Candicort®, Nizoral®, Baycuten N® - Tinea | Phase 3 | Completed | Ache Laboratorios Farmaceuticos S.A. | 125 | 2019-06-11 | 2021-09-20 |
| To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases TD03, TD07, Ketoconazole 2% Shampoo - Scalp Dermatitis | Phase 3 | Unknown | Sao Thai Duong Joint Stock Company | 366 | 2019-05-22 | 2022-10-26 |
| Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Ketoconazole, Terconazole - Vaginal Candidiasis | Phase 3 | Unknown | Assiut University | 69 | 2018-04-01 | 2018-03-22 |
| Non-inferiority Trial of Dapaconazole Versus Ketoconazole Dapaconazole, Ketoconazole - Tinea Pedis | Phase 3 | Completed | Biolab Sanus Farmaceutica | 360 | 2017-11-01 | 2020-07-27 |
| Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis Dapaconazole, Ketoconazole - Tinea Pedis | Phase 3 | Withdrawn | Biolab Sanus Farmaceutica | 2016-06-01 | 2017-02-01 | |
| Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis Clindamycin 100mg and Ketoconazole 400mg, Tetracycline 100mg and Amphotericin B 50mg - Candidiasis, Bacterial Vaginosis | Phase 3 | Unknown | Zodiac Produtos Farmaceuticos S.A. | 160 | 2009-09-01 | 2009-04-28 |
| An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot Placebo cream, Ketoconazole 2% cream (formulation F012) (Nizoral), Ketoconazole 2% cream (formulation F126) - Tinea Pedis | Phase 3 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 583 | 2007-07-01 | 2014-04-29 |
| Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 1126 | 2004-01-01 | 2019-11-29 |
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer docetaxel, estramustine phosphate sodium, ketoconazole - Prostate Cancer | Phase 3 | Completed | Eastern Cooperative Oncology Group | 2003-10-08 | 2023-06-15 | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer bicalutamide, docetaxel, doxorubicin hydrochloride - Prostate Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 21 | 2002-10-01 | 2020-10-22 |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Docetaxel, Doxorubicin hydrochloride, Estramustine phosphate sodium - Prostate Cancer | Phase 3 | Terminated | M.D. Anderson Cancer Center | 265 | 2002-04-01 | 2016-03-22 |
| Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer ketoconazole, therapeutic hydrocortisone, Withdrawal of antiandrogen therapy - Prostate Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 260 | 1996-08-01 | 2016-06-28 |
| Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Bicalutamide, Doxorubicin hydrochloride, Estramustine Phosphate Sodium - Prostate Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 306 | 1996-08-01 | 2018-10-31 |
| Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Low Tidal Volume Ventilation, Positive End-Expiratory Pressure, Lysofylline - Respiratory Distress Syndrome, Adult, Lung Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1994-09-01 | 2016-03-23 |
Prostatic Neoplasms (5) · Tinea Pedis (3) · Mycoses (2) · Burns (1) · Candidiasis (1) · Candidiasis, Vulvovaginal (1) · Cellulitis (1) · Dermatomycoses (1) · Lung Diseases (1) · Motor Activity (1) · Respiratory Distress Syndrome (1) · Tinea (1) · Vaginosis, Bacterial (1)
Biolab Sanus Farmaceutica (2) · M.D. Anderson Cancer Center (2) · Ache Laboratorios Farmaceuticos S.A. (1) · Alliance for Clinical Trials in Oncology (1) · Assiut University (1) · Eastern Cooperative Oncology Group (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Radiation Therapy Oncology Group (1) · Sao Thai Duong Joint Stock Company (1) · The University of Texas Medical Branch, Galveston (1) · Zodiac Produtos Farmaceuticos S.A. (1)
United States (7) · Brazil (4) · Australia (1) · Canada (1) · Peru (1) · Poland (1) · Puerto Rico (1) · United Kingdom (1) · Vietnam (1)
Gregory P. Swanson, MD (2) · Alan Morris, MD (1) · Alfred F. Connors, MD (1) · Antonio Anzueto, MD (1) · Arif Hussain, MD (1) · Arthur Wheeler, MD (1) · David A. Schoenfeld, PhD (1) · David N Herndon, MD (1) · Edward Abraham, MD (1) · Eric Small, MD (1) · Gilberto De Nucci, MD (1) · Gilberto De Nucci, PhD (1) · Gregory A. Schmidt, MD, FCCP (1)
PMID 12560440, PMID 14747052, PMID 15020604, PMID 16258090, PMID 17404083, PMID 18401254, PMID 19029421, PMID 19734776, PMID 20881067, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622
P30CA016672 (2), N01HR56165 (1), N01HR56166 (1), N01HR56167 (1), N01HR56168 (1), N01HR56169 (1), N01HR56170 (1), N01HR56171 (1), N01HR56172 (1), N01HR56173 (1), N01HR56174 (1), N01HR56175 (1), N01HR56176 (1), N01HR56179 (1), P50GM060338 (1)